OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2021
(3)
2016
(3)
2022
(2)
2019
(2)
2020
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Observation of Preferential Pathways for Oxygen Removal through Porous Transport Layers of Polymer Electrolyte Water Electrolyzers.
Not available
S-EPMC7691172
|
biostudies-literature
Cite
Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women.
Not available
S-EPMC8971982
|
biostudies-literature
Cite
Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring.
Not available
S-EPMC6395928
|
biostudies-literature
Cite
Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.
Not available
S-EPMC4786336
|
biostudies-literature
Cite
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.
Not available
S-EPMC8663550
|
biostudies-literature
Cite
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Not available
S-EPMC9077443
|
biostudies-literature
Cite
On the issue of transparency and reproducibility in nanomedicine.
Not available
S-EPMC6939883
|
biostudies-literature
Cite
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288
|
biostudies-literature
Cite
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
Not available
S-EPMC8038210
|
biostudies-literature
Cite
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Not available
S-EPMC8189692
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets